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Abstract
Background: Automated adverse outcome surveillance tools and methods have potential utility in quality
improvement and medical product surveillance activities. Their use for assessing hospital performance on the basis
of patient outcomes has received little attention. We compared risk-adjusted sequential probability ratio testing
(RA-SPRT) implemented in an automated tool to Massachusetts public reports of 30-day mortality after isolated
coronary artery bypass graft surgery.
Methods: A total of 23,020 isolated adult coronary artery bypass surgery admissions performed in Massachusetts
hospitals between January 1, 2002 and September 30, 2007 were retrospectively re-evaluated. The RA-SPRT method
was implemented within an automated surveillance tool to identify hospital outliers in yearly increments. We used
an overall type I error rate of 0.05, an overall type II error rate of 0.10, and a threshold that signaled if the odds of
dying 30-days after surgery was at least twice than expected. Annual hospital outlier status, based on the state-
reported classification, was considered the gold standard. An event was defined as at least one occurrence of a
higher-than-expected hospital mortality rate during a given year.
Results: We examined a total of 83 hospital-year observations. The RA-SPRT method alerted 6 events among three
hospitals for 30-day mortality compared with 5 events among two hospitals using the state public reports, yielding
a sensitivity of 100% (5/5) and specificity of 98.8% (79/80).
Conclusions: The automated RA-SPRT method performed well, detecting all of the true institutional outliers with a
small false positive alerting rate. Such a system could provide confidential automated notification to local
institutions in advance of public reporting providing opportunities for earlier quality improvement interventions.
Background
Public reporting of risk adjusted mortality rates follow-
ing cardiac surgery has become an important tool in the
evaluation and improvement of quality of patient care
[1]. Several states, including Massachusetts, have
enacted legislation requiring public reporting of cardiac
surgical outcome data [2]. Beginning in 2002, all Massa-
chusetts hospitals performing cardiac surgery were
required to submit cardiac surgical outcomes data to
the Massachusetts Data Analysis Center (Mass-DAC), a
data coordinating center for the Massachusetts Depart-
ment of Public Health (MA DPH), and to the Society of
Thoracic Surgeons (STS) using the STS National Car-
diac Database collection tool. Since then, Mass-DAC
has published annual public reports on 30-day, all-
cause, risk-adjusted mortality rates for isolated coronary
artery bypass surgery (CABG) for institutions, and
beginning in 2004, for individual cardiac surgeons [3].
Though public reports are intended to provide trans-
parency and public accountability, and to inform consu-
mer choice, there are other consequences to public
reporting that have potentially significant long-term,
financial and reputational impact on both the institu-
tions and providers. In Massachusetts, two centers were
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liers, one of which was identified as such in multiple,
consecutive years [4,5]. As a result, this cardiac surgery
program was temporarily suspended while quality
improvement initiatives were undertaken [6]. Notifica-
tion of the first year of outlier status for this program
was not available publicly until 2 to 2.75 years after data
collection (relative to calendar quarter) [5,6].
There are inherent delays between performance of
procedures and public reporting of outcomes due to the
rigorous data review and manual case adjudication
required from both a regulatory and data quality stand-
point. Massachusetts has steadily decreased the delay
between data collection and public reporting since the
program’s inception in 2002, currently reduced for fiscal
year 2008 to 1.25 to 2 years (relative to calendar quar-
ter) [7]. However, any temporal delays between the per-
formance of the procedure and the analysis and public
reporting of results is undesirable and could expose
some patients to increased risk of morbidity and mortal-
i t ya sp r o c e d u r e sc o n t i n u et ob ep e r f o r m e dw h i l ea
quality issue exists. An active, automated prospective
surveillance system, as an adjunct to the existing rigor-
ous regulatory approach, could provide institutions or
physicians timely internal feedback and provide oppor-
tunities to mitigate these risks well in advance of public
release of the data.
We designed the Data Extraction and Longitudinal
Trend Analysis (DELTA) system to provide real-time
monitoring of clinical data to support continuous quality
or safety monitoring of newly approved medical devices,
medications, or therapeutic interventions [8]. This sys-
tem supports a variety of frequentist and Bayesian statis-
tical methods, which can be configured to provide
unadjusted and risk-adjusted safety monitoring among
prospective and retrospective cohorts [8-11]. DELTA
also incorporates de-identification and encryption algo-
rithms to guard protected health information and con-
trol data ownership, and employs flexible alerting
mechanisms to trigger notifications via e-mail or
through the web interface when an observed event rate
exceeds boundaries of risk-adjusted expectations for the
event of interest.
Risk-adjusted SPRT, a method for observational cohort
safety surveillance, was first proposed by Spiegelhalter
and colleagues [12]. This method has been used to evalu-
ate hospital and physician performance among retrospec-
tive cohorts for coronary artery bypass patients and
percutaneous coronary intervention patients [12-14].
While this method has not achieved widespread use, it is
well suited for implementation in a prospective, auto-
mated system because it analyzes each sequential case
and incorporates adjustment for repeated measures on
the same subject with explicit type I and II error rates.
In this study, we sought to assess the utility of Risk-
Adjusted Sequential Probability Ratio testing when
imbedded in an automated surveillance tool as com-
pared to the gold standard of retrospective annual qual-
ity reports used by the Massachusetts Department of
Public Health (MA-DPH). The primary outcomes of this
analysis were the sensitivity and specificity of the auto-
mated implementation as compared with the public
reporting methods of Massachusetts Data Analysis Cen-
ter (MASS-DAC) and the MA-DPH, assessed for hospi-
tal 30-day mortality after isolated coronary artery bypass
graft surgery.
Methods
Study Setting
Massachusetts regulations require all acute care non-
federal hospitals that provide cardiac surgery to collect
data using a standardized data collection instrument
based on the Society of Thoracic Surgery (STS) registry
[15]. Each institution is required to submit data on a
quarterly basis to Mass-DAC, and participating centers
collect the data using a variety of point-of-care collec-
tion tools, chart review, and patient follow-up. Mass-
DAC performs manual adjudication of all cases with
a d v e r s eo u t c o m e sa sw e l la sas a m p l eo fa l lo t h e rc a s e
records. Yearly reports of hospital and surgeon 30-day
mortality performance are published. Additional infor-
mation and annual public reports are available online
[3].
A total of 23,020 isolated adult coronary artery bypass
surgery admissions were conducted from January 1,
2002 to September 30, 2007. The surgeries did not
involve valve replacement or other associated cardiac
surgical procedures. We selected these surgeries for our
study because the state uses them as the primary index
of institution and surgeon quality for cardiovascular sur-
gery. In 2006, Mass-DAC changed reporting from a
calendar year basis to a fiscal year basis that runs from
October 1 through September 30. Consequently, the
2006 fiscal year analysis included the last three months
of the 2005 calendar year. The primary patient outcome
of the registry is the 30-day all-cause mortality after iso-
lated coronary artery bypass graft surgery. We focused
on 30-day all-cause hospital-specific risk-standardized
mortality rates. The current study was approved by the
Brigham & Women’s and Harvard Medical School’s
Institutional Review Boards.
Gold Standard Statistical Analysis
Mass-DAC reports the data annually utilizing Bayesian
hierarchical logistic regression [1]. The model assumes
that the log-odds of mortality is linearly related to a set
of patient risk factors and permits baseline risk to vary
across hospitals through the inclusion of a hospital-
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including the between-hospital variance, hospital overall
mean log-odds, and regression coefficients of patient-
level risk factors are obtained via Markov chain Monte
Carlo (MCMC) methods. The MCMC method uses the
Gibbs sampler to sequentially sample from probability
distributions and produces a Markov chain with the
joint posterior density as its stationary distribution [16].
This is accomplished by selecting a set of starting
values, then performing a number of “burn-in” sampling
iterations that are not recorded, followed by the collec-
tion and averaging of additional sampling iterations to
form the final posterior estimates. The primary analysis
used all of the data for the year and declared a hospital
as an outlier if the lower limit of the 95% posterior
interval of the risk-adjusted institutional standardized
mortality rate exceeded the unadjusted statewide mor-
tality rate. Because of the small number of cardiac sur-
gery hospitals in Massachusetts, Mass-DAC also
performs cross-validation analyses in which each hospi-
tal is eliminated and data from the remaining hospitals
are used to assess hospital performance in the elimi-
nated hospital. This strategy was developed to avoid one
large center from having too great an influence on state-
wide risk expectations. A hospital was considered an
outlier if either the 95% posterior interval from the sta-
tewide comparison exceeded the unadjusted statewide
mortality rate or the posterior predictive p-value from
the cross-validation analysis was 0.01 or smaller.
Hospital 9 was declared an outlier in the 2002-2005
reports, and hospital 8 was declared an outlier in the 2004
report. All of hospital outliers were detected with only the
cross-validation evaluation by MASS-DAC. Although the
original 2002 public report did not include the cross-vali-
dation analysis method, we have exactly reproduced this
analysis protocol on this data to provide consistency
across all years. A summary of the risk-adjusted standar-
dized mortality incidence rate (with upper and lower limits
of the 95% interval) by hospital and year are reported in
Figure 1. The dotted line in the figure represents the state-
wide unadjusted mortality incidence rate, and values in
red indicated an outlying hospital.
Automated Risk Adjusted Sequential Probability Ratio
Testing (RA-SPRT)
The SPRT control chart methodology detects unaccep-
table event rates by evaluating each unit of analysis
sequentially in time [12,13]. The risk hypothesis is
whether the observed outcome event rate exceeds the
accepted or baseline event rate given a specific odds
ratio (OR) and Type I and II error [12]. This method
accepts or rejects this hypothesis after each sequential
case is evaluated. Risk adjustment is performed through
the use of a risk prediction model whereby the
cumulative log likelihood ratio is adjusted by the prob-
ability of the outcome [17]. Repeated measurement (re-
analysis after each additional case) error adjustments are
incorporated explicitly in the framework. These features
are uncommon in statistical process control methods
and are strengths of this method.
The following describes the calculations necessary to
construct risk-adjusted SPRT control charts as refined
by Rogers and colleagues[13] based on Spiegelhalter’s
work [12]. The control limits are defined by
h0 =
ln

1 − α
β

ln(OR)
(1)
and
h1 =
ln

1 − β
α

ln(OR)
(2)
where h0 and h1 are the cumulative log-likelihood
ratio values in which the null hypothesis (H0)o rt h e
alternate hypothesis (H1) is accepted (respectively), OR
is the odds ratio, a is the type I error rate, and b is the
type II error rate.
The cumulative log-likelihood ratio value (T
cum)i s
calculated in sequence for higher risk detection (OR >
1) with
TCum
i = TCum
i−1 +( Oi − si) (3)
where T0
cum =0 ,O i is the observed outcome (0 or 1)
for a binary procedure for i
th case, and
si =
ln((1 − pi)+( OR ∗ pi))
ln(OR)
(4)
where pi is the calculated probability of the outcome
for the i
th case as determined by the risk prediction
model.
We have previously described an automated real-time
safety monitoring tool, Data Extraction and Longitudinal
Trend Analysis (DELTA), that is able to perform larger
numbers of concurrent prospective analyses using a
variety of statistical methodologies and alerting thresh-
olds [18]. The system uses a SQL 2005 server (Microsoft
Corp., Redmond, WA) to provide internal data storage
and configuration information, as well as providing the
capability to integrate with external databases. The user
interface was developed in the Microsoft. NET program-
ming environment and was displayed in a web browser
from a Microsoft IIS 6.0 Web Server (Microsoft Corp.,
Redmond, WA). Security of patient data is further
addressed by record de-identification steps and user
login access restrictions [19].
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within DELTA, and the statistical module evaluated the
data after setting cohort inclusion and exclusion criteria
as well as the necessary statistical parameters, such as
the desired odds ratio and the type I and II error.
Parameters and risk variable selection for the logistic
regression risk adjustment were then passed through a
bi-directional interface to SAS (Version 9.1, Cary, NC)
in order to develop the required logistic regression
models.
Figure 1 Gold Standard Results for MASSDAC CABG by year.E a c hn u m b e ro nt h eya x i sw i t h i ne a c h year represents a unique hospital.
Circles represent posterior mean risk-standardized mortality rates for each institution; lines are corresponding 95% posterior intervals. The
hospitals in red alerted from the cross-validation method only.
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The risk-adjusted sequential probability ratio testing
(RA-SPRT) method was used to evaluate the data sepa-
rately for each calendar or fiscal year. Although one of
the strengths of this method is that it can accumulate
data continuously until the alerting odds ratio hypoth-
esis is accepted or rejected, analyses were terminated at
the end of each calendar or fiscal year and the cumula-
tive log-likelihood ratio was reset to 0. This was done in
order to be directly comparable to the gold standard.
Risk adjustment was performed using standard logistic
regression with the same risk factors used in the source
method by Mass-DAC. Each logistic regression model
was developed from data in the prior 11 months and
then applied sequentially to each case in the “current”
month. This process was repeated throughout the entire
range of the data. Data were not available prior to 2002,
so the models developed prior to December 2002 used
from one to ten months of data (depending on the ana-
lysis month). Data from January 2002 were not analyzed
by RA-SPRT because they were required to build the
first model. It should be noted that the risk models
developed from the first two months of data showed
regression coefficient instability and poor calibration, as
w o u l db ee x p e c t e dw i t hl o ws a m p l es i z e s .B o t ho ft h e s e
measurements subsequently stabilized for the remainder
of the data. A type I error of 0.05 and type II error level
of 0.10 were used in each of the RA-SPRT analyses, and
an OR threshold of 2.0 was defined as the reasonable
thresholds for concern regarding the clinical quality of
the institution evaluated. An outlier was declared if a
hospital exceeded the log likelihood ratio threshold at
any point during that calendar year.
Results
A total of 23,020 isolated coronary artery bypass graft
surgeries were evaluated from January 1
st, 2002 to Sep-
tember 30
th,2 0 0 7 ,a n d9 2 5c a s e si nt h el a s tq u a r t e ro f
2005 were included in both calendar year 2005 and fis-
cal year 2006 evaluations to be consistent with MASS-
DAC reporting. The annual 30-day mortality rate ranged
from 1.41 percent to 2.19 percent with a general
decreasing trend. Most of the risk factors included in
the risk models were stable across years, with the excep-
tions of declining prior CABG surgeries, increasing prior
percutaneous coronary transluminal angiography proce-
dures, and declining cardiogenic shock rates. A sum-
mary of patient risk factor prevalence and outcome
event rates by year are shown in Table 1. The risk-
adjusted SPRT method detected three hospitals with
outlying 30-day mortality outcomes. Hospital 4 experi-
enced a false positive alert in 2002 (Figure 2A), Hospital
8 experienced a true positive alert in 2004 (Figure 2B),
and Hospital 9 experienced true positive alerts in 2002,
2003, 2004, and 2005 (Figure 2C). The remaining eva-
luations for each hospital were true negatives (for exam-
ple, Hospital 6 shown in Figure 2D). This resulted in a
sensitivity of RA-SPRT of 100% (5/5) and the specificity
was 98.8% (79/80) compared to the publicly available
reports.
Discussion
The automated RA-SPRT method within DELTA per-
formed well applied to a statewide clinical registry data
over a number of years when compared with the
method used by the state to produce the public report-
ing of institutional and physician performance reports.
The method detected each of the true outliers and gen-
erated a single false positive, which is a desirable profile
for an early detection system used for knowledge discov-
ery and internal quality improvement initiatives. Due to
the frequent periodic analysis that the method employs,
the DELTA system would have reported these findings
to the local institutions significantly earlier than they
were available publicly.
In general, an automated outcomes surveillance sys-
tem, whether used for post-marketing surveillance or
institutional and physician profiling, should be tuned
with appropriate error levels and alerting thresholds to
be over-sensitive in a manner similar to a screening test,
where it is highly desirable to capture all of the true sig-
nals and tolerance to false positive signals is dependent
on the resources that are available to perform root
cause analyses and further data exploration. The RA-
SPRT method did perform in this manner in this data
set using stock values for types I and II error rates, and
a common odds ratio threshold, which is encouraging,
but does require further validations in other clinical
domains to increase the generalizability of these find-
ings. Selection of a desirable false positive versus false
negative threshold depends on the clinical domain’s
desire to avoid missing a true signal and the cost of per-
forming more in depth analysis of each detected signal.
In addition, processing time was very reasonable within
the automated application, and a quarter of data was
able to be analyzed in seconds, with the most time con-
suming step being that of logistic regression model gen-
eration in each month analyzed.
The RA-SPRT method has a number of strengths,
including explicit alerting boundary thresholds and
incorporation of repeated testing [12-14]. It should be
noted that the RA-SPRT method uses a simple hypoth-
esis rather than a composite hypothesis that tests all
odds ratios greater than 1.0 for statistical significance.
This could potentially result in a statistically significant
odds ratio less than the selected threshold (such as 1.1
or 1.2) that is not detected as an outlier by the method.
However, in many cases, such an alert may not be
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ratio threshold that would be clearly clinically
significant.
There are a number of limitations to this work. It
should be noted that the sensitivity and specificity are
optimistic in that implementation of this system in a
prospective setting would eliminate the time costly man-
ual data adjudication and outcome chart review steps
t h a ta r ed o n eb yM a s s - D A C ,a tt h ee x p e n s eo ft h e
accuracy of the data analyzed. Another limitation in the
use of this system is the timing of data submission by
the sites. Currently, data are submitted quarterly, rather
than monthly (as used in this analysis), by MA cardiac
institutions. The RA-SPRT method is intended for
sequential case level analysis and performing the analysis
in larger time segments results in over-correction of the
repeated measurement adjustment. Real-time data sur-
veillance would be ideal, but requires a regular and
Table 1 Summary information for patient and institutions by year.
2002 2003 2004 2005 2006 2007
Number of Hospitals (count) 13 14 14 14 14 14
Number of Admissions (count) 4604 4393 3986 3885 3684 3396
30-Day Crude Mortality 2.17 2.25 2.01 1.65 1.41 1.47
(1.77-2.63) (1.84-2.74) (1.60-2.49) (1.27-2.10) (1.06-1.85) (1.09-1.94)
Mean Age in Years (SD) 66.5 66.7 66.9 66.5 66.5 66.0
(10.7) (10.6) (10.7) (10.8) (10.7) (10.9)
Male 74.5 73.5 74.5 76.4 75.2 75.9
(73.2-75.8) (72.2-74.8) (73.1-75.9) (75.1-77.8) (73.8-76.7) (74.4-77.3)
Renal Failure 7.3 6.9 5.8 6.4 6.6 7.5
(6.6-8.1) (6.2-7.7) (5.1-6.6) (5.6-7.2) (5.8-7.4) (6.6-8.4)
Diabetes Mellitus 38.0 38.1 37.0 39.3 39.4 42.6
(36.6-39.4) (36.6-39.5) (35.5-38.5) (37.8-40.8) (37.9-41.0) (40.9-44.3)
Hypertension 77.0 79.5 82.7 83.9 84.1 83.5
(75.7-78.2) (78.3-80.7) (81.1-83.5) (82.7-85.1) (82.9-85.3) (82.2-84.8)
Peripheral Vascular Disease 18.0 17.4 17.7 17.4 17.4 17.4
(16.9-19.2) (16.3-18.5) (16.5-18.9) (16.3-18.7) (16.1-18.6) (16.1-18.7)
Prior CABG Surgery 3.8 3.1 2.6 2.5 1.8 2.1
(3.3-4.4) (2.6-3.7) (2.1-3.2) (2.0-3.0) (1.4-2.3) (1.6-2.6)
Prior PTCA/PCI 18.6 17.8 19.1 20.2 21.0 21.6
(17.5-19.8) (16.7-18.9) (17.8-20.3) (19.0-21.6) (19.7-22.3) (20.2-23.0)
Cardiogenic Shock 2.2 1.6 1.1 1.0 0.9 0.8
(1.8-2.7) (1.3-2.0) (0.8-1.5) (0.7-1.4) (0.6-1.2) (0.5-1.1)
Ejection Fraction
<30% or missing 12.8 12.6 11.8 11.6 10.1 10.4
(11.9-13.9) (11.4-13.4) (10.8-12.8) (10.6-12.7) (9.1-11.1) (9.5-11.6)
30 - 39 11.7 12.4 11.0 10.9 10.0 10.5
(10.8-12.7) (11.4-13.4) (10.1-12.0) (9.9-11.9) (9.0-11.0) (9.5-11.6)
Myocardial Infarction
Within 24 Hours 2.7 3.2 3.8 2.9 3.3 3.3
(2.3-3.2) (2.6-3.7) (3.3-4.5) (2.4-3.5) (2.7-3.9) (2.7-4.0)
1 - 7 days 20.7 23.0 22.1 23.1 23.4 24.5
(19.5-21.9) (21.7-24.2) (20.8-23.4) (21.8-24.4) (22.0-24.8) (23.1-26.0)
Status of CABG Surgery
Urgent 62.0 65.8 66.6 61.3 59.6 62.3
(60.1-63.4) (64.3-37.2) (65.1-68.0) (59.8-62.8) (58.0-61.2) (60.7-64.0)
Emergent/Salvage 3.7 2.9 3.1 2.5 2.6 3.3
((3.2-4.3) (2.4-3.4) (2.6-3.7) (2.0-3.0) (2.1-3.1) (2.7-3.9)
Pre-op Intra-Aortic Balloon Pump 9.3 11.7 11.6 10.9 11.2 11.3
(8.5-10.2) (10.7-12.6) (10.6-12.6) (9.9-11.9) (10.2-12.3) (10.2-12.4)
Years 2002-2005 were collected in the calendar year, and 2006-2007 were collected in the fiscal year from October of the previous year to September of the
reported year. All data are percents (with 95% confidence intervals) unless otherwise specified as means (with standard deviations).
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institution. In order to evaluate this potential and evalu-
ate the impact of lack of data adjudication, we are cur-
rently conducting percutaneous coronary angiography
prospective surveillance in a subset of institutions in the
state with the necessary infrastructure for near real-time
submission.
Conclusions
The RA-SPRT method implemented within an auto-
mated surveillance system was able to detect institu-
tional outliers in a statewide clinical registry. While
either a significant electronic health record infrastruc-
ture or a state reporting mechanism is required to rea-
lize the full utility of this system for outcome profiling,
it could result in significant time savings in providing
early warnings to local institutions and physicians.
Acknowledgements
This study was funded in part by grants R01-LM-008142 from the National
Library of Medicine, FDA-SOL-08-00837A from the Food and Drug
Administration, and VA HSR&D CDP-09-387 from the Veteran’s
Administration Health Services Research and Development Service. We
would like to acknowledge Richard Cope and Coping Systems for their
technical expertise and programming work.
Author details
1GRECC and Center for Health Services Research, Tennessee Valley
Healthcare System, Veterans Administration, Nashville, TN, USA.
2Division of
General Internal Medicine and Public Health, Vanderbilt University Medical
Center, Nashville, TN, USA.
3Department of Biomedical Informatics, Vanderbilt
University Medical Center, Nashville, TN, USA.
4Department of Health Care
Policy, Harvard Medical School and Department of Biostatistics, Harvard
Figure 2 Yearly RA-SPRT results (OR 2.0) for selected hospitals in which the graph was reset at the beginning of each year. The upper
threshold represents the alternate hypothesis (H1) confirming the odds ratio for the outcome ≥ 2.0, and the lower threshold represents the null
hypothesis (H0) there was not an elevated odds ratio for the outcome ≥ 2.0. Years are calendar years except 2006-2007, which were fiscal years
October - September. A) Hospital 4, B) Hospital 8, C) Hospital 9, D) Hospital 6.
Matheny et al. BMC Medical Informatics and Decision Making 2011, 11:75
http://www.biomedcentral.com/1472-6947/11/75
Page 7 of 8School of Public Health, Boston, MA, USA.
5Food and Drug Administration,
Center for Devices and Radiological Health, Silver Spring, MD, USA.
6Division
of Cardiology, Brigham & Women’s Hospital, Boston, MA, USA.
Authors’ contributions
MEM participated in the conception and design of the study, analysis and
interpretation of the data, drafting of the manuscript, and critical revision of
the manuscript. STN participated in the conception and design of the study,
acquisition of the data, analysis and interpretation of the data, and critical
revision of the manuscript. TPG, DMD, NLB, and SD participated in the
conception and design of the study and critical revision of the manuscript.
VDV participated in analysis and interpretation of the data and critical
revision of the manuscript. FSR participated in the conception and design of
the study, analysis and interpretation of the data, and critical revision of the
manuscript. All authors read and approved the final manuscript.
Competing interests
A patent application by Frederic Resnic, Michael Matheny, and Richard Cope
for several key analytic components of DELTA is currently under review at
the U.S. Patent Office. As current and former employees of Brigham &
Women’s Hospital, the intellectual property rights of Frederic Resnic and
Michael Matheny related to the development of DELTA are assigned to the
institution. Neither Frederic Resnic nor Michael Matheny have previously
received nor anticipate any financial compensation, stock options, income,
or ownership in DELTA, Coping Systems, or any other related commercial
entity. Michael Matheny has no consulting income to report, and Frederic
Resnic reports having modest consulting income from Boston Scientific Inc.,
Abbott Vascular Inc., Cordis Corp., and St. Jude Medical Inc., as well as
research grants from The Medicines Company. Dr. Normand receives minor
consulting income from the Medicines Company and Analytica International.
Received: 10 December 2010 Accepted: 14 December 2011
Published: 14 December 2011
References
1. Shahian DM, Normand SL, Torchiana DF, Lewis SM, Pastore JO, Kuntz RE,
Dreyer PI: Cardiac surgery report cards: comprehensive review and
statistical critique. Ann Thorac Surg 2001, 72(6):2155-2168.
2. Shahian DM, Torchiana DF, Normand SL: Implementation of a cardiac
surgery report card: lessons from the Massachusetts experience. Ann
Thorac Surg 2005, 80(3):1146-1150.
3. Massachusetts Data Analysis Center. [http://www.massdac.org/].
4. Shahian DM, Normand SL: Comparison of “risk-adjusted” hospital
outcomes. Circulation 2008, 117(15):1955-1963.
5. Publicly Released Reports for the Commonwealth of Massachusetts
Cardiac Surgery Cohort. [http://www.massdac.org/reports/surgery.html].
6. Ettinger WH, Hylka SM, Phillips RA, Harrison LH Jr, Cyr JA, Sussman AJ:
When things go wrong: the impact of being a statistical outlier in
publicly reported coronary artery bypass graft surgery mortality data.
Am J Med Qual 2008, 23(2):90-95.
7. Time-line summary for the reporting of cardiac surgery project of the
Massachusetts Data analysis Center (MASS-DAC). [http://massdac.org/
sites/default/files/CSTimelines.pdf].
8. Matheny ME, Ohno-Machado L, Resnic FS: Monitoring device safety in
interventional cardiology. J Am Med Inform Assoc 2006, 13(2):180-187.
9. Resnic FS, Zou KH, Do DV, Apostolakis G, Ohno-Machado L: Exploration of
a bayesian updating methodology to monitor the safety of
interventional cardiovascular procedures. Med Decis Making 2004,
24(4):399-407.
10. Matheny ME, Arora N, Ohno-Machado L, Resnic FS: Rare Adverse Event
Monitoring of Medical Devices with the Use of an Automated
Surveillance Tool. AMIA Annu Symp Proc 2007, 518-522.
11. Matheny ME, Morrow DA, Ohno-Machado L, Cannon CP, Sabatine MS,
Resnic FS: Validation of an automated safety surveillance system with
prospective, randomized trial data. Med Decis Making 2009, 29(2):247-256.
12. Spiegelhalter D, Grigg O, Kinsman R, Treasure TOM: Risk-adjusted
sequential probability ratio tests: applications to Bristol, Shipman and
adult cardiac surgery. Int J Qual Health Care 2003, 15(1):7-13.
13. Rogers CA, Reeves BC, Caputo M, Ganesh JS, Bonser RS, Angelini GD:
Control chart methods for monitoring cardiac surgical performance and
their interpretation. J Thorac Cardiovasc Surg 2004, 128(6):811-819.
14. Matheny ME, Ohno-Machado L, Resnic FS: Risk-adjusted sequential
probability ratio test control chart methods for monitoring operator and
institutional mortality rates in interventional cardiology. Am Heart J 2008,
155(1):114-120.
15. Shahian DM, Blackstone EH, Edwards FH, Grover FL, Grunkemeier GL,
Naftel DC, Nashef SAM, Nugent WC, Peterson ED: Cardiac Surgery Risk
Models: A Position Article. Ann Thorac Surg 2004, 78(5):1868-1877.
16. Kass RE, Carlin BP, Gelman A, Neal RM: Markov Chain Monte Carlo in
Practice: A Roundtable Discussion. The American Statistician 1998,
52(2):93-100.
17. Steiner SH, Cook RJ, Farewell VT, Treasure T: Monitoring surgical
performance using risk-adjusted cumulative sum charts. Biostatistics 2000,
1(4):441-452.
18. Matheny ME, Ohno-Machado L, Resnic FS: Monitoring device safety in
interventional cardiology. J Am Med Inform Assoc 2006, 13(2):180-187,
Epub 2005 Dec 2015.
19. Standards for Privacy of Individually Identifiable Health Information:
Final Rule. Federal Register 2002, 67(157):53182-53273.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6947/11/75/prepub
doi:10.1186/1472-6947-11-75
Cite this article as: Matheny et al.: Evaluation of an automated safety
surveillance system using risk adjusted sequential probability ratio
testing. BMC Medical Informatics and Decision Making 2011 11:75.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Matheny et al. BMC Medical Informatics and Decision Making 2011, 11:75
http://www.biomedcentral.com/1472-6947/11/75
Page 8 of 8